Clin2
NCT06008860Possibly a fitRecruiting

Astepro nasal spray for early COVID-19

COVID-19

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether Astepro nasal spray can help people with mild or no COVID-19 symptoms recover faster. If you have tested positive and are vaccinated, you may qualify.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
280 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have tested positive for COVID-19 (via saliva test or rapid antigen test)
  • You have no symptoms or only mild symptoms (like no fever or mild fever, no severe cough)
  • You have been vaccinated against COVID-19
  • You can provide saliva samples every other day for 10 days and report symptoms
  • You are not pregnant, breastfeeding, or planning to become pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06768697Not yet recruiting· Early Phase 1
Nasal spray boost for COVID-19 immunity

This trial tests a nasal spray that may boost your immune system against COVID-19. It's for people who had the COVID-19 vaccine at least 6 months ago and haven't had COVID-19 recently.

Shanghai, Jinshan District
NCT05041907Recruiting· Phase 2
Testing an antiviral’s effects in early COVID-19

This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.

Minas Gerais
NCT04709328Not yet recruiting· Phase 2/Phase 3
Testing an antibody treatment for high-risk COVID-19 patients

This study tests a new antibody medicine for people with COVID-19 who are at high risk of getting very sick. If you qualify, you would receive the study drug or a placebo (inactive substance) to see if it helps you recover without needing to go to the hospital.

NCT06667063Recruiting
Immune response study for COVID-19 and flu

This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.

Wuhan, Hubei
NCT07536308Recruiting· Phase 1
Nasal COVID-19 booster vaccine safety trial

This trial tests a new nasal spray COVID-19 booster vaccine. It aims to see if the vaccine is safe and produces a strong immune response when given through the nose and inhaled, in people who have already been vaccinated.

Decatur, Georgia
NCT07262450Recruiting
Seawater spray for stuffy nose and sinus symptoms

This trial tests whether a seawater nasal spray can relieve nasal congestion, runny nose, and other sinus symptoms in people with colds, allergies, or after nose surgery. You will use the spray as directed and answer online questionnaires for up to 3 months.

Bordeaux

Hear when a new COVID-19 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.